Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin
Open accessAbstract
The emerging fungal pathogen Candida auris causes invasive infections and is spreading in hospitals worldwide. Why this species exhibits the capacity to transfer efficiently among patients is unknown. Our findings reveal that C. auris forms high-burden biofilms in conditions mimicking sweat on the skin surface. These adherent biofilm communities persist in environmental conditions expected in the hospital setting. Using a pig skin model, we show that C. auris also forms high-burden biofilm structures on the skin surface. Identification of this mode of growth sheds light on how this recently described pathogen persists in hospital settings and spreads among patients.
AI snapshot
Written from the paper’s full text.
TL;DR
Candida auris forms high-burden biofilms in synthetic human sweat and on ex vivo porcine skin, exceeding Candida albicans under these skin-niche conditions. These biofilms persist through sweat evaporation and desiccation, suggesting a mechanism for hospital persistence and spread.
Key findings
- In synthetic human axillary sweat, C. auris produced biofilms with 10-fold greater burden than C. albicans after 24 h (P < 0.05), while in RPMI-MOPS C. albicans biofilm biomass was 3-fold greater than C. auris (P < 0.05).
- In concentrated synthetic sweat, C. auris biofilms were 10-fold greater than C. albicans at 1.5× and 4-fold greater at 2.5×. After 24 h desiccation, C. auris burden was approximately 30-fold greater than C. albicans at 7 days; at 14 days C. auris grew readily while C. albicans biofilms were not viable.
- On porcine skin, C. auris reached a burden nearly 15-fold greater than C. albicans and replicated nearly 100-fold above the initial inoculum (P < 0.05); scanning electron microscopy showed multilayer yeast-cell biofilms without tissue invasion.
Methods
- Biofilm assays used C. albicans SC5314 and C. auris strains from the CDC, including B11203, grown in RPMI-MOPS or synthetic human axillary sweat medium; burden was measured by OD600, and architecture was imaged by scanning electron microscopy.
- Desiccation assays grew biofilms for 24 h, desiccated them in a laminar flow hood for 24 h, then assessed viable burden after 7 or 14 days by plating on YPD agar.
- The ex vivo skin model used full-thickness 12-mm skin samples from Wisconsin Miniature Swine, placed in DMEM with 10% FBS and a paraffin barrier, inoculated on the epidermal surface with Candida in synthetic sweat medium, incubated 24 h, and assessed by CFU counts and scanning electron microscopy.
Limitations
- The paper states no limitations.
- Evident from the text: the main skin model is ex vivo porcine skin, not human skin, and the in vitro work uses synthetic sweat medium rather than native human sweat.
- Evident from the text: most experiments use C. auris strain B11203, although a CDC strain set spanning clades was tested for initial biofilm formation; mechanisms of desiccation resistance and biofilm formation are not determined.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
8 of 20 cited sources checked · 6 supported · 0 flagged · accuracy not yet measured
- Findingown data
On porcine skin, C. auris forms multilayer biofilms composed of yeast cells.
“Higher magnification imaging showed the formation of multilayer biofilms composed of yeast cells.”
Quote in the paperSubstantial claim - Findingown data
In synthetic sweat medium mimicking human axillary sweat, after 24 h, C. auris produced biofilms with 10-fold greater burden than C. albicans.
“After 24 h of incubation, C. auris produced dense biofilms with 10-fold greater burden than the biofilms formed by C. albicans (Fig. 1a) (P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
In RPMI-MOPS, the biomass of biofilms formed by C. albicans was 3-fold greater than for C. auris.
“For example, in RPMI-MOPS (morpholinepropanesulfonic acid), the biomass of biofilms formed by C. albicans was 3-fold greater than for C. auris (Fig. 1a) (P < 0.05), consistent with prior studies demonstrating lower biofilm burdens for this species (8, 9).”
Quote in the paperSubstantial claim - Findingown data
Even in 2.5×-concentrated synthetic sweat, C. auris exhibited the capacity to proliferate as a biofilm.
“Even in 2.5×-concentrated sweat, C. auris exhibited the capacity to proliferate as a biofilm.”
Quote in the paperSubstantial claim - Findingown data
C. auris forms high-burden biofilms in conditions mimicking sweat on the skin surface.
“Our findings reveal that C. auris forms high-burden biofilms in conditions mimicking sweat on the skin surface.”
Quote in the paperSubstantial claim
- Findingown data
In 1.5×-concentrated synthetic sweat, C. auris formed high-burden biofilms 10-fold greater than C. albicans.
“In 1.5×-concentrated synthetic sweat, C. auris formed high-burden biofilms, 10-fold greater than C. albicans, mirroring the findings observed for the nonconcentrated sweat (Fig. 1c).”
Quote in the paperSubstantial claim - Findingown data
Examination of the fungal-epithelial interface for both species revealed intact skin without evidence of tissue invasion.
“Examination of the fungal-epithelial interface for both species revealed intact skin without evidence of tissue invasion.”
Quote in the paperSubstantial claim - Findingown data
The majority of C. auris strains appeared to have a slight growth advantage over C. albicans in sweat medium under nonbiofilm conditions.
“Indeed, the majority of C. auris strains appeared to have a slight growth advantage over C. albicans in the sweat medium under nonbiofilm conditions (see Fig. S2).”
Quote in the paperNot a substantial claim - Findingown data
At 7 days postdesiccation, C. auris persisted at a burden approximately 30-fold greater than C. albicans.
“At 7 days postdesiccation, we found C. auris to persist at a burden approximately 30-fold greater than C. albicans (Fig. 1d).”
Quote in the paperSubstantial claim - Findingown data
C. auris growing in synthetic sweat medium proliferates as a multilayer biofilm composed entirely of yeast cells.
“Consistent with quantitative biofilm formation assays, C. auris growing in synthetic sweat medium replicated that on the coverslip surface, proliferating as a multilayer biofilm, composed entirely of yeast cells (Fig. 1b).”
Quote in the paperSubstantial claim - Findingown data
C. albicans growing in synthetic sweat medium forms a rudimentary biofilm composed of yeast with rare pseudohyphae or hyphae.
“In contrast, C. albicans formed a very rudimentary biofilm, composed of yeast with rare pseudohyphae or hyphae.”
Quote in the paperSubstantial claim - Findingown data
C. auris resists desiccation during biofilm formation.
“Our finding that C. auris resists desiccation during biofilm formation may not be surprising, as a prior study has shown this species to survive dry conditions for up to 2 weeks (21).”
Quote in the paperSubstantial claim - Premisecitation
Miniature swine varieties more closely mimic human body composition than conventional pigs.
“As conventional pigs have been bred for increased size and muscle mass, miniature varieties more closely mimic human body composition (14, 15).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [14] Schomberg DT, Tellez A, Meudt JJ, Brady DA, Dillon KN, Arowolo FK, Wicks J, Rousselle SD, Shanmuganayagam D 2016 Miniature swine for preclinical modeling of complexities of human disease for translational scientific discovery and accelerated development of therapies and medical devices. Toxicol Pathol 44: 299– 314. doi: 10.1177/0192623315618292. 26839324 source
- cites [15] Liu Y, Chen JY, Shang HT, Liu CE, Wang Y, Niu R, Wu J, Wei H 2010 Light microscopic, electron microscopic, and immunohistochemical comparison of Bama minipig (Sus scrofa domestica) and human skin. Comp Med 60: 142– 148. 20412690 PMC2855042
- Interpretationown data
C. auris B11203 appeared representative of the C. auris isolates.
“As C. auris B11203 appeared representative of the C. auris isolates, we continued to utilize this strain for subsequent experiments.”
Quote in the paperSubstantial claim - Interpretationown data
Biofilms formed by C. auris in conditions of the skin microenvironment persist despite conditions of both sweat evaporation and environmental desiccation.
“Taken together, these results illustrate that biofilms formed by C. auris in conditions of the skin microenvironment persist despite conditions of both sweat evaporation and environmental desiccation.”
Quote in the paperSubstantial claim - Interpretationown data
Robust biofilm formation in skin niche conditions is a common characteristic for C. auris.
“The findings show that robust biofilm formation in skin niche conditions is a common characteristic for C. auris.”
Quote in the paperSubstantial claim - Premisecitation
A C. auris outbreak in the United Kingdom was linked to the use of reusable axillary temperature probes.
“As an example, a C. auris outbreak in the United Kingdom was linked to the use of reusable axillary temperature probes (20).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, Newnham R, Sunderland M, Clarke T, Foster D, Hoffman P, Borman AM, Johnson EM, Moore G, Brown CS, Walker AS, Peto TEA, Crook DW, Jeffery KJM 2018 A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 379: 1322– 1331. doi: 10.1056/NEJMoa1714373. 30281988 source
- Interpretationown data
The small growth differences between C. auris and C. albicans in nonbiofilm conditions did not account for the 10-fold greater biofilm formation observed for C. auris.
“However, these relatively small differences did not account for the 10-fold greater biofilm formation observed for C. auris (Fig. 1a and S1).”
Quote in the paperSubstantial claim - Interpretationown data
C. auris exhibits an enhanced propensity to proliferate on porcine skin.
“Furthermore, the results reveal that C. auris exhibits an enhanced propensity to proliferate on porcine skin.”
Quote in the paperSubstantial claim - Interpretationown data
C. auris exhibits a heightened capacity to form biofilms in the milieu of the skin surface.
“These findings show that C. auris exhibits a heightened capacity to form biofilms in the milieu of the skin surface.”
Quote in the paperSubstantial claim - Premisecitation
Porcine skin serves as an excellent model for studies of wound healing, infection, and skin colonization.
“In light of the similarities to human skin, porcine skin serves as an excellent model for studies of wound healing, infection, and skin colonization (15–18, 25).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [15] Liu Y, Chen JY, Shang HT, Liu CE, Wang Y, Niu R, Wu J, Wei H 2010 Light microscopic, electron microscopic, and immunohistochemical comparison of Bama minipig (Sus scrofa domestica) and human skin. Comp Med 60: 142– 148. 20412690 PMC2855042
- cites [16] Eaglstein WH, Mertz PM 1978 New methods for assessing epidermal wound healing: the effects of triamcinolone acetonide and polyethelene film occlusion. J Invest Dermatol 71: 382– 384. doi: 10.1111/1523-1747.ep12556814. 722115 source
- cites [17] Sullivan TP, Eaglstein WH, Davis SC, Mertz P 2001 The pig as a model for human wound healing. Wound Repair Regen 9: 66– 76. doi: 10.1046/j.1524-475x.2001.00066.x. 11350644 source
- cites [18] Summerfield A, Meurens F, Ricklin ME 2015 The immunology of the porcine skin and its value as a model for human skin. Mol Immunol 66: 14– 21. doi: 10.1016/j.molimm.2014.10.023. 25466611 source
- cites [25] Giotis ES, Loeffler A, Knight-Jones T, Lloyd DH 2012 Development of a skin colonization model in gnotobiotic piglets for the study of the microbial ecology of meticillin-resistant Staphylococcus aureus ST398. J Appl Microbiol 113: 992– 1000. doi: 10.1111/j.1365-2672.2012.05397.x. 22805003 source
- Interpretationreasoning
The United Kingdom C. auris outbreak likely involved robust biofilm growth similar to that observed in the present study.
“Given the axillary skin environment in this setting, we propose that the outbreak likely involved robust biofilm growth similar to that observed in the present study.”
Quote in the paperNot a substantial claim
- May combine two claims. 12
- Classified as probably not a substantial claim. 6
May combine two claims.
Interpretationown dataThese observations help explain C. auris's propensity for colonizing skin, persisting on hospital surfaces, and spreading efficiently in the hospital setting.
“These observations help to explain this pathogen’s propensity for colonizing skin, persisting on hospital surfaces, and spreading efficiently in the hospital setting (4, 19).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [4] Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC 2016 First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5: 35. doi: 10.1186/s13756-016-0132-5. 27777756 PMC5069812 source
- cites [19] Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, Kemble SK, Pacilli M, Black SR, Landon E, Ridgway J, Palmore TN, Zelzany A, Adams EH, Quinn M, Chaturvedi S, Greenko J, Fernandez R, Southwick K, Furuya EY, Calfee DP, Hamula C, Patel G, Barrett P, MSD, Lafaro P, Berkow EL, Moulton-Meissner H, Noble-Wang J, Fagan RP, Jackson BR, Lockhart SR, Litvintseva AP, Chiller TM 2016 Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep 65: 1234– 1237. doi: 10.15 source
The main report (page unavailable in our copy) documents skin colonization weeks to months after infection and C. auris on multiple surfaces in one hospital room. It says these findings suggest spread in health care settings is possible, but transmission was not definitively documented; it does not establish how long the organism persisted on surfaces or that it spread efficiently. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationCirculating C. auris strains vary genetically and cluster into at least 4 distinct clades.
“Circulating C. auris strains vary genetically and cluster into at least 4 distinct clades (1).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [1] Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP 2017 Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64: 134– 140. doi: 10.1093/cid/ciw691. 27988485 PMC5215215 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDay and colleagues showed that C. auris exhibited a unique stress resistance profile compared to other Candida spp.
“However, studies by Day and colleagues characterized the responses of Candida to a variety of stresses, including high salinity, and showed that C. auris exhibited a unique stress resistance profile compared to those of other Candida spp. (22).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [22] Day AM, McNiff MM, da Silva Dantas A, Gow NAR, Quinn J 2018 Hog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris. mSphere 3: e00506-18. doi: 10.1128/mSphere.00506-18. 30355673 PMC6200985 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe stress responses studied by Day and colleagues involved the evolutionarily conserved Hog1 stress-activated protein kinase (SAPK).
“Despite the different profiles, these responses involved the evolutionarily conserved Hog1 stress-activated protein kinase (SAPK).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [22] Day AM, McNiff MM, da Silva Dantas A, Gow NAR, Quinn J 2018 Hog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris. mSphere 3: e00506-18. doi: 10.1128/mSphere.00506-18. 30355673 PMC6200985 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA prior study has shown C. auris to survive dry conditions for up to 2 weeks.
“as a prior study has shown this species to survive dry conditions for up to 2 weeks (21).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [21] Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP 2017 Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55: 2996– 3005. doi: 10.1128/JCM.00921-17. 28747370 PMC5625385 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe karyotypic plasticity displayed by C. auris in response to stressors may contribute to this organism's ability to adapt and persist in the skin niche.
“In addition, the karyotypic plasticity displayed by C. auris in response to stressors may contribute to this organism’s ability to adapt and persist in the skin niche (23).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [23] Bravo Ruiz G, Ross ZK, Holmes E, Schelenz S, Gow NAR, Lorenz A 2019 Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates. Curr Genet 65: 1217– 1228. doi: 10.1007/s00294-019-00976-w. 31020384 PMC6744574 source
The Results section (‘C. auris undergoes karyotype rearrangements in stress conditions’; page unavailable) documents stress-induced karyotype changes, and the Discussion suggests such changes might aid fitness adaptation. The Introduction describes C. auris as a skin colonizer, but the paper does not link karyotypic plasticity to adaptation or persistence in the skin niche. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIndividual C. auris strains appear to have arisen independently in remote geographic locations.
“What is striking about C. auris is that individual strains appear to have arisen independently in remote geographic locations (1).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP 2017 Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64: 134– 140. doi: 10.1093/cid/ciw691. 27988485 PMC5215215 source
May combine two claims.
Findingown dataIn RPMI-MOPS, C. albicans forms dense biofilms composed primarily of hyphae, while C. auris forms a monolayer of yeast.
“In this tissue culture medium, C. albicans formed dense biofilms composed primarily of hyphae, while biofilms formed by C. auris appeared as a monolayer of yeast.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBiofilm growth by the majority of C. auris strains paralleled strain B11203, with burdens reaching approximately 10-fold that of C. albicans.
“Biofilm growth by the majority of the strains paralleled that observed for C. auris B11203 (listed as strain 5), with burdens reaching approximately 10-fold that of C. albicans (see Fig. S1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOn porcine skin, C. auris exhibited enhanced growth compared to C. albicans, propagating to a burden nearly 15-fold greater than C. albicans and replicating nearly 100-fold above the initial inoculum.
“Consistent with our in vitro observations, C. auris exhibited enhanced growth compared to that of C. albicans in this environment, with C. auris propagating to a burden nearly 15-fold greater than C. albicans and replicating nearly 100-fold above the initial inoculum (Fig. 2b) (P < 0.05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOn porcine skin, C. albicans showed little fungal growth and multilayer aggregates were not observed.
“In contrast, imaging of porcine skins inoculated with C. albicans showed little fungal growth. Multilayer aggregates were not observed.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 14 days postdesiccation, C. auris grew readily from biofilms, while C. albicans biofilms were not viable.
“At 14 days postdesiccation, C. auris grew readily from biofilms, while C. albicans biofilms were not viable (Fig. 1e).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 2.5×-concentrated synthetic sweat, C. auris biofilm burdens were below those formed in less-concentrated sweat but were still 4-fold greater than C. albicans biofilms.
“The burdens of these biofilms were below those formed in the less-concentrated sweat but were still 4-fold greater than the biofilms formed by C. albicans.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPig skin shares many characteristics with human skin, including similarities in the thickness of skin layers, the types and distribution of skin cells, and the mechanisms of skin repair.
“Pig skin was selected based on the many characteristics it shares with human skin, including similarities in the thickness of skin layers, the types and distribution of skin cells, and the mechanisms of skin repair (15–18).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [15] Liu Y, Chen JY, Shang HT, Liu CE, Wang Y, Niu R, Wu J, Wei H 2010 Light microscopic, electron microscopic, and immunohistochemical comparison of Bama minipig (Sus scrofa domestica) and human skin. Comp Med 60: 142– 148. 20412690 PMC2855042
- cites [16] Eaglstein WH, Mertz PM 1978 New methods for assessing epidermal wound healing: the effects of triamcinolone acetonide and polyethelene film occlusion. J Invest Dermatol 71: 382– 384. doi: 10.1111/1523-1747.ep12556814. 722115 source
- cites [17] Sullivan TP, Eaglstein WH, Davis SC, Mertz P 2001 The pig as a model for human wound healing. Wound Repair Regen 9: 66– 76. doi: 10.1046/j.1524-475x.2001.00066.x. 11350644 source
- cites [18] Summerfield A, Meurens F, Ricklin ME 2015 The immunology of the porcine skin and its value as a model for human skin. Mol Immunol 66: 14– 21. doi: 10.1016/j.molimm.2014.10.023. 25466611 source
May combine two claims.
Interpretationown dataGrowth in synthetic sweat medium and on porcine skin allows C. auris to form dense biofilms that flourish in conditions of evaporation and resist desiccation.
“Our findings demonstrate that growth in synthetic sweat medium and on porcine skin allows C. auris to form dense biofilms that flourish in conditions of evaporation and resist desiccation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe lack of tissue invasion supports the use of porcine skin to model human skin colonization, as this process does not involve tissue destruction by fungi.
“This lack of invasion supports the use of porcine skin to model human skin colonization, as this process does not involve tissue destruction by fungi.”
Quote in the paperSubstantial claim- Rests on an assumption: Human skin colonization by C. auris does not involve tissue destruction by fungi.
May combine two claims.
Interpretationown dataGrowth of C. auris in the ex vivo porcine skin model mimics what is observed clinically, an enhanced capacity for skin colonization.
“Growth of C. auris in this ex vivo model mimics what is observed clinically, an enhanced capacity for skin colonization.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Human skin colonization by C. auris does not involve tissue destruction by fungi.
“This lack of invasion supports the use of porcine skin to model human skin colonization, as this process does not involve tissue destruction by fungi.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinical features of C. auris infections include biofilm persistence on abiotic surfaces and skin, immune evasion, and antifungal drug resistance.
“The clinical features of these infections include biofilm persistence on abiotic surfaces and skin, immune evasion, and antifungal drug resistance (7–12).”
From Dual function of <i>Candida auris</i> mannosyltransferase, MNT5, in biofilm community protection from antifungal therapy and the host (2025) · cites this paper as [12]
The Introduction and Discussion (page unavailable) describe C. auris colonizing skin, persisting on hospital surfaces, and forming biofilms under skin-like conditions. The paper does not establish immune evasion or antifungal drug resistance as clinical features; searching those terms yielded references to other studies, not findings reported in the paper’s text. (LLM, conf=0.87)
Experimental — accuracy not yet measuredIn an in vitro artificial human axillary sweat medium, C. auris achieves a fungal burden 10 times greater than C. albicans and persists during colonization for over 14 days, whereas C. albicans does not.
“In an in vitro model using an artificial human axillary sweat medium, C. auris achieves a fungal burden 10 times greater than Candida albicans and persists during colonization for over 14 days, which was not observed in C. albicans18.”
From Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins (2025) · cites this paper as [18]
The Results section (“C. auris forms high-burden biofilms in skin milieu”) reports a 10-fold greater C. auris biofilm burden than C. albicans in synthetic sweat medium. The Results section on desiccation reports viable C. auris at 14 days postdesiccation, while C. albicans biofilms were not viable. It does not establish persistence for over 14 days or describe that result as persistence during colonization. (LLM, conf=0.88)
Experimental — accuracy not yet measuredC. auris can grow and persist for extensive periods under skin-like conditions in simulation studies and animal models.
“Several simulation studies and animal models have demonstrated that C. auris can grow and persist for extensive periods under skin-like conditions.”
From <i>Candida auris</i> metabolism and growth preferences in physiologically relevant skin-like conditions (2026) · cites this paper as [21]
The Results report growth on ex vivo porcine skin after 24 hours and survival of biofilms formed in synthetic sweat medium for up to 14 days after desiccation. These findings support growth and persistence under simulated skin-like conditions, but the paper's porcine-skin experiment is not a live-animal model, and the extended persistence was shown in the biofilm experiment rather than on porcine skin. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Cites
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 6× · see citing works
“auris strains vary genetically and cluster into at least 4 distinct clades (1).”
BackgroundMethodInfluentialBiofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343 · cited 1× · see citing works
“communities encased within a protective extracellular matrix (6, 7).”
BackgroundThe pig as a model for human wound healing
Sullivan, T. P., Eaglstein, W. H., Davis, S. C., & Mertz, P. (2001) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2001.00066.x · Cited by 1,091 · see citing works
<i>Candida</i> Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · cited 1× · see citing works
“communities encased within a protective extracellular matrix (6, 7).”
BackgroundFirst hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768 · cited 2× · see citing works
“auris efficiently colonizes the skin, persists on hospital surfaces, and rapidly spreads among patients (1, 3, 4).”
BackgroundThe immunology of the porcine skin and its value as a model for human skin
Summerfield, A., Meurens, F., & Ricklin, M. E. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.023 · Cited by 551 · see citing works
A <i>Candida auris</i> Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · cited 1× · see citing works
“auris outbreak in the United Kingdom was linked to the use of reusable axillary temperature probes (20).”
BackgroundOn the emergence of Candida auris: climate change, azoles, swamps, and birds
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2019) · mBio · doi:10.1128/mbio.01397-19 · Cited by 515 · cited 1× · see citing works
“auris has not been described, one hypothesis is that increasing temperatures due to climate change promoted the emergence of this species that could then thrive in the high temperatures of mammalian and avian hosts (24).”
BackgroundWelsh, R. M., Bentz, M. L., Shams, A., Houston, H., Lyons, A., Rose, L. J., & Litvintseva, A. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-17 · Cited by 499 · cited 1× · see citing works
“auris resists desiccation during biofilm formation may not be surprising, as a prior study has shown this species to survive dry conditions for up to 2 weeks (21).”
Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces
Kuhn, D. M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.878-888.2002 · Cited by 485 · see citing works
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant <i>Candida auris</i>
Sherry, L., Ramage, G., Kean, R., Borman, A., Johnson, E. M., Richardson, M. D., & Rautemaa-Richardson, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161320 · Cited by 420 · cited 1× · see citing works
“05), consistent with prior studies demonstrating lower biofilm burdens for this species (8, 9).”
ResultLarkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395 · cited 1× · see citing works
“05), consistent with prior studies demonstrating lower biofilm burdens for this species (8, 9).”
ResultCandida auris candidaemia in Indian ICUs: analysis of risk factors
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · cited 1× · see citing works
“auris efficiently colonizes the skin, persists on hospital surfaces, and rapidly spreads among patients (1, 3, 4).”
BackgroundVallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544e1 · Cited by 302 · see citing works
<i>Candida auris</i> in Healthcare Facilities, New York, USA, 2013–2017
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., Greenko, J., Fernandez, R., Kallen, A., Vallabhaneni, S., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2410.180649 · Cited by 284 · see citing works
Kean, R., Delaney, C., Sherry, L., Borman, A., Johnson, E. M., Richardson, M. D., Rautemaa-Richardson, R., Williams, C., & Ramage, G. (2018) · mSphere · doi:10.1128/msphere.00334-18 · Cited by 220 · see citing works
Eaglstein, W. H., & Mertz, P. M. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12556814 · Cited by 171 · see citing works
Nett, J. E., Cain, M. T., Crawford, K., & Andes, D. R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02273-10 · Cited by 153 · cited 1× · see citing works
“For biofilm assays, 200 l was added to flat-bottom 96-well microtiter plates (30).”
MethodSelf-citationJohnson, C. J., Cabezas‐Olcoz, J., Kernien, J. F., Wang, S. X., Beebe, D. J., Anna Huttenlocher, A., Ansari, H., & Nett, J. E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005884 · Cited by 132 · cited 1× · see citing works
“Candida biofilms were examined by scanning electron microscopy as previously described (32, 33).”
MethodSelf-citationConserved Role for Biofilm Matrix Polysaccharides in <i>Candida auris</i> Drug Resistance
Dominguez, E. G., Zarnowski, R., Choy, H. L., Zhao, M., Sanchez, H., Nett, J. E., & Andes, D. R. (2019) · mSphere · doi:10.1128/mspheredirect.00680-18 · Cited by 132 · see citing works
Self-citationHog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris
Day, A. M., McNiff, M. M., da Silva Dantas, A., Gow, N. A. R., & Quinn, J. (2018) · mSphere · doi:10.1128/msphere.00506-18 · Cited by 116 · see citing works
Schomberg, D. T., Tellez, A., Meudt, J. J., Brady, D. A., Dillon, K. N., Arowolo, F. K., Wicks, J., Rousselle, S. D., & Shanmuganayagam, D. (2016) · Toxicologic Pathology · doi:10.1177/0192623315618292 · Cited by 97 · cited 3× · see citing works
“auris growth in the skin niche, we developed an ex vivo porcine skin model employing the Wisconsin Miniature Swine (14).”
BackgroundMethodSelf-citationThe Candida auris Alert: Facts and Perspectives
Lamoth, F., & Kontoyiannis, D. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix597 · Cited by 95 · cited 1× · see citing works
“auris has emerged as the first fungal pathogen to be designated a global public health threat (2).”
BackgroundBiofilm formation by <i>Candida auris</i> isolated from colonising sites and candidemia cases
Singh, R., Kaur, M., Chakrabarti, A., Shankarnarayan, S. A., & Rudramurthy, S. M. (2019) · Mycoses · doi:10.1111/myc.12947 · Cited by 86 · see citing works
Artificial sweat composition to grow and sustain a mixed human axillary microbiome
Callewaert, C., Buysschaert, B., Vossen, E., Fievez, V., de Wiele, T. V., & Boon, N. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.05.005 · Cited by 77 · cited 2× · see citing works
“In place of fatty acids hydrolyzed from human abdominal subcutaneous fat, we included a mix of the three most abundance fatty acids found in human sweat (lauric, myristic, and palmitic fatty acids) (26, 27).”
Background(2010) · PubMed Central · Cited by 73 · see citing works
Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays
Lohse, M. B., Gulati, M., Arevalo, A. V., Fishburn, A. T., Johnson, A. D., & Nobile, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02749-16 · Cited by 65 · cited 1× · see citing works
“The biofilm burdens were then measured by optical density at 600 nm (OD600) values obtained using a microplate reader (Synergy H1; Bio-Tek Instruments) (31).”
MethodRapid and extensive karyotype diversification in haploid clinical Candida auris isolates
Bravo Ruiz, G., Ross, Z. K., Holmes, E., Schelenz, S., Gow, N. A. R., & Lorenz, A. (2019) · Current Genetics · doi:10.1007/s00294-019-00976-w · Cited by 60 · cited 1× · see citing works
“auris in response to stressors may contribute to this organism’s ability to adapt and persist in the skin niche (23).”
BackgroundJohnson, C. J., Kernien, J. F., Hoyer, A. R., & Nett, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-13588-6 · Cited by 58 · cited 1× · see citing works
“Candida biofilms were examined by scanning electron microscopy as previously described (32, 33).”
MethodSelf-citationStudies on the Chemistry of Human Perspiration with Especial Reference to its Lactic Acid Content
Thurmon, F. M., & Ottenstein, B. (1952) · Journal of Investigative Dermatology · doi:10.1038/jid.1952.38 · Cited by 49 · cited 1× · see citing works
“Cholesterol and lactic acid concentrations were selected based on prior measurements for sweat (28, 29).”
MethodFree fatty acids and sterols in human eccrine sweat
TAKEMURA, T., Wertz, P. W., & SATO, K. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb07764.x · Cited by 36 · cited 1× · see citing works
“Cholesterol and lactic acid concentrations were selected based on prior measurements for sweat (28, 29).”
MethodDetermination of Fatty Acids in Human Sweat during Fasting Using GC/MS
Nunome, Y., Tsuda, T., & Kitagawa, K. (2010) · Analytical Sciences · doi:10.2116/analsci.26.917 · Cited by 20 · cited 1× · see citing works
“In place of fatty acids hydrolyzed from human abdominal subcutaneous fat, we included a mix of the three most abundance fatty acids found in human sweat (lauric, myristic, and palmitic fatty acids) (26, 27).”
BackgroundGiotis, E. S., Loeffler, A., Knight-Jones, T., & Lloyd, D. H. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05397.x · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2021) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 511 · see citing works
The rapid emergence of antifungal-resistant human-pathogenic fungi
Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 315 · see citing works
“colonization and increase the risk of a disseminated infection 56–58 .”
BackgroundDrug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 294 · see citing works
“Of particular concern is the tendency of this species to cause clonal outbreaks in clinical settings [38–41], which likely reflects its resilience on the skin and hospital surfaces, possibly due to biofilm production [42].”
BackgroundProctor, D. M., Dangana, T., Sexton, D. J., Fukuda, C., Yelin, R. D., Stanley, M., Bell, P. B., Baskaran, S., Deming, C., Chen, Q., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01383-w · Cited by 198 · see citing works
Santana, D. J., Anku, J. A. E., Zhao, G., Zarnowski, R., Johnson, C. J., Hautau, H., Visser, N. D., Ibrahim, A. S., Andes, D., Nett, J. E., et al. (2023) · Science · doi:10.1126/science.adf8972 · Cited by 142 · see citing works
Self-citationChakrabarti, A., & Sood, P. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001318 · Cited by 132 · see citing works
“Once in the environment, C. auris rapidly adapts to the dry abiotic milieu by activating the stress-activated protein kinase, Hog1, which provides it resilience against desiccation and helps maintain its cell morphology [116, 117].”
InfluentialCandida auris Infection and Biofilm Formation: Going Beyond the Surface
Horton, M. V., & Nett, J. E. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00143-7 · Cited by 132 · see citing works
“The degree of this biofilmassociated drug resistance varies by species and antifungal, with biofilms withstanding up to 1000×-fold higher concentrations of antifungals compared to planktonic cells. Consequently, one would speculate that biofilm formation is likely to be associated with increased antifungal tolerance f…”
Self-citationSweat and Sebum Preferences of the Human Skin Microbiota
Swaney, M. H., Nelsen, A., Sandstrom, S., & Kalan, L. R. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04180-22 · Cited by 96 · see citing works
“158 To develop an artificial sweat that is consistent with the composition of human eccrine sweat and 159 is suitable for microbial growth, we developed a formulation considering previously described 160 synthetic sweat media (12, 14) and through extrapolating eccrine sweat constituents and their 161 concentrations as…”
BackgroundMethodInfluentialSelf-citationCandida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast
Kean, R., Brown, J. L., Gülmez, D., Ware, A., & Ramage, G. (2020) · Journal of Fungi · doi:10.3390/jof6010030 · Cited by 86 · see citing works
“auris had the capacity to proliferate and form multilayer biofilm communities [40].”
BackgroundWhat do we know about the biology of the emerging fungal pathogen of humans Candida auris?
Ruiz, G. B., & Lorenz, A. (2020) · Microbiological Research · doi:10.1016/j.micres.2020.126621 · Cited by 83 · see citing works
What Do We Know about Candida auris? State of the Art, Knowledge Gaps, and Future Directions
García-Bustos, V., Cabañero-Navalón, M. D., Ruiz‐Saurí, A., Gaitán, A. C. R., Salavert, M., Tormo‐Más, M. Á., & Pemán, J. (2021) · Microorganisms · doi:10.3390/microorganisms9102177 · Cited by 82 · see citing works
“Beyond phenotypic plasticity, some works have reported the ability of this fungus to evade neutrophil attack and effective phagocytosis both in human and animal models [116,122].”
BackgroundEnvironmental reservoirs of the drug-resistant pathogenic yeast Candida auris
Akinbobola, A., Kean, R., Hanifi, S. M. A., & Quilliam, R. S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011268 · Cited by 78 · see citing works
Candida auris Phenotypic Heterogeneity Determines Pathogenicity <i>In Vitro</i>
Brown, J. L., Delaney, C., Short, B., Butcher, M. C., McKloud, E., Williams, C., Kean, R., & Ramage, G. (2020) · mSphere · doi:10.1128/msphere.00371-20 · Cited by 76 · see citing works
“auris (B11203 strain, as above) formed 13 high-burden biofilms on porcine skin biopsies in the presence of an artificial sweat 14 medium [17].”
BackgroundMechanisms of pathogenicity for the emerging fungus Candida auris
Horton, M. V., Holt, A. M., & Nett, J. E. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011843 · Cited by 67 · see citing works
Self-citationOne population, multiple lifestyles: Commensalism and pathogenesis in the human mycobiome
Proctor, D. M., Drummond, R. A., Lionakis, M. S., & Segre, J. A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.02.010 · Cited by 68 · see citing works
Allert, S., Schulz, D., Kämmer, P., Großmann, P., Wolf, T., Schäuble, S., Panagiotou, G., Brunke, S., & Hube, B. (2022) · Virulence · doi:10.1080/21505594.2022.2026037 · Cited by 66 · see citing works
The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen
Santana, D. J., Zhao, G., & O’Meara, T. R. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012011 · Cited by 62 · see citing works
Vila, T., Montelongo-Jauregui, D., Ahmed, H., Puthran, T., Sultan, A. S., & Jabra-Rizk, M. A. (2020) · mSphere · doi:10.1128/msphere.00760-20 · Cited by 58 · see citing works
Shivarathri, R., Jenull, S., Stoiber, A., Chauhan, M., Mazumdar, R., Singh, A., Nogueira, F., Kuchler, K., Chowdhary, A., & Chauhan, N. (2020) · mSphere · doi:10.1128/msphere.00973-20 · Cited by 59 · see citing works
“auris and pose the single most important threat for person-to-person transmission (60).”
BackgroundForgotten fungi: the importance of the skin mycobiome
Nguyen, U. T., & Kalan, L. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102235 · Cited by 59 · see citing works
Self-citationPriority effects dictate community structure and alter virulence of fungal-bacterial biofilms
Cheong, J. Z. A., Johnson, C. J., Wan, H., Liu, A., Kernien, J. F., Gibson, A. L. F., Nett, J. E., & Kalan, L. (2021) · The ISME Journal · doi:10.1038/s41396-021-00901-5 · Cited by 57 · see citing works
Self-citationCandida auris: A Continuing Threat
Bhargava, A., Klamer, K., Sharma, M., Ortiz, D. A., & Saravolatz, L. I. I. (2025) · Microorganisms · doi:10.3390/microorganisms13030652 · Cited by 58 · see citing works
“These adherent biofilm communities explain the propensity of C. auris to colonize skin and persist in environmental conditions expected in the hospital setting [77].”
Álvarez, C., Morales-López, S. E., Rodríguez, G. J., Rodríguez, J. Y., Robert, E., Picot, C., Ceballos-Garzón, A., Parra‐Giraldo, C. M., & Pape, P. L. (2023) · Journal of Fungi · doi:10.3390/jof9040430 · Cited by 48 · see citing works
Augmenting the Activity of Chlorhexidine for Decolonization of Candida auris from Porcine skin
Johnson, C. J., Eix, E. F., Lam, B. C., Wartman, K. M., Meudt, J. J., Shanmuganayagam, D., & Nett, J. E. (2021) · Journal of Fungi · doi:10.3390/jof7100804 · Cited by 45 · see citing works
Self-citationEix, E. F., Johnson, C. J., Wartman, K. M., Kernien, J. F., Meudt, J. J., Shanmuganayagam, D., Gibson, A. L. F., & Nett, J. E. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac094 · Cited by 41 · see citing works
Self-citationPublic Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives
Smith, D. J., Gold, J. A. W., Benedict, K., Wu, K., Lyman, M., Jordan, A., Medina, N., Lockhart, S. R., Sexton, D. J., Chow, N. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9080820 · Cited by 39 · see citing works
Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles
Elias, R., Basu, P., & Fridman, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01807 · Cited by 39 · see citing works
Overview about Candida auris: What's up 12 years after its first description?
Désoubeaux, G., Coste, A. T., Imbert, C., & Hennequin, C. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101248 · Cited by 38 · see citing works
NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
Cleare, L. G., Li, K. L., Abuzeid, W. M., Nacharaju, P., Friedman, J. M., & Nosanchuk, J. D. (2020) · Journal of Fungi · doi:10.3390/jof6020085 · Cited by 36 · see citing works
“auris formed biofilms in both synthetic sweat media, mimicking the physiologic conditions of the axilla, and on porcine skin [13].”
BackgroundEssential Oils as a Good Weapon against Drug-Resistant Candida auris
Fernandes, L., Ribeiro, R., Costa, R. H. S., Henriques, M., & Rodrigues, M. E. (2022) · Antibiotics · doi:10.3390/antibiotics11070977 · Cited by 36 · see citing works
Candida auris from colonisation to candidemia: A four‐year study
Bayona, J. V. M., Tormo, N., García, C. S., Serrano, M. D. R. G., & Cardona, C. G. (2023) · Mycoses · doi:10.1111/myc.13626 · Cited by 36 · see citing works
Candida auris:a fungus with identity crisis
Vila, T. V. M., Sultan, A. S., Montelongo‐Jauregui, D., & Jabra‐Rizk, M. A. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa034 · Cited by 37 · see citing works
Transcriptome Signatures Predict Phenotypic Variations of Candida auris
Jenull, S., Tscherner, M., Kashko, N., Shivarathri, R., Stoiber, A., Chauhan, M., Petryshyn, A., Chauhan, N., & Kuchler, K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.662563 · Cited by 32 · see citing works
“The top downregulated genes encompassed several cell wall-associated proteins such as homologues of the C. albicans ALS4 and PGA7, encoding for an adhesin (Hoyer et al., 1998) and a GPI-anchored cell wall protein (Sorgo et al., 2013), respectively (Figure 3B).”
BackgroundZhao, G., Lyu, J., Veniaminova, N. A., Zarnowski, R., Mattos, E., Johnson, C. J., Quintanilla, D., Hautau, H., Hold, L. A., Xu, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60876-1 · Cited by 32 · see citing works
Self-citationMariita, R. M., Davis, J., Lottridge, M. M., & Randive, R. V. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1261 · Cited by 29 · see citing works
“Some of these features include the ability to spread rapidly, persistence in the colonization of the skin and high‐touch surfaces (Horton Mark et al., 2020), and resistance to common disinfectants (Vila et al., 2020).”
BackgroundThe skin mycobiome and intermicrobial interactions in the cutaneous niche
Tuor, M., & LeibundGut-Landmann, S. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102381 · Cited by 30 · see citing works
Candida auris Biofilm Colonization on Skin Niche Conditions
Uppuluri, P. (2020) · mSphere · doi:10.1128/msphere.00972-19 · Cited by 29 · see citing works
“(13) have taken the first steps to understand the interaction of C.”
BackgroundInfluentialCall to Action: How to Tackle Emerging Nosocomial Fungal Infections
Lionakis, M. S., & Hohl, T. M. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.011 · Cited by 30 · see citing works
Native human and mouse skin infection models to study Candida auris-host interactions
Seiser, S., Arzani, H., Ayub, T., Phan-Canh, T., Staud, C., Worda, C., Kuchler, K., & Elbe-Bürger, A. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2023.105234 · Cited by 29 · see citing works
Jaromin, A., Żarnowski, R., Markowski, A., Zagórska, A., Johnson, C. J., Etezadi, H., Kihara, S., Mota‐Santiago, P., Nett, J. E., Boyd, B. J., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00955-23 · Cited by 27 · see citing works
“Skin biopsies (12 mm) were obtained and prepared as previously described (27, 41).”
MethodSelf-citationSkin and hard surface disinfection against Candida auris – What we know today
Omardien, S., & Teska, P. J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1312929 · Cited by 29 · see citing works
Candida Infections: The Role of Saliva in Oral Health—A Narrative Review
Tamai, R., & Kiyoura, Y. (2025) · Microorganisms · doi:10.3390/microorganisms13040717 · Cited by 27 · see citing works
“Compared with C. albicans , C. auris exhibits enhanced biofilm formation in synthetic sweat media, mimicking skin niche conditions [249].”
Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections
Hetta, H. F., Ramadan, Y. N., Al-Kadmy, I. M. S., Ellah, N. H. A., Shbibe, L., & Battah, B. (2023) · Pathogens · doi:10.3390/pathogens12081033 · Cited by 24 · see citing works
“auris biofilms have been proven to withstand artificial dehydration [48].”
Barião, P. H. G., Tonani, L., Brancini, G. T. P., Nascimento, É., Braga, G. Ú. L., Wainwright, M. S., & Kress, M. R. V. Z. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00258-4 · Cited by 26 · see citing works
“auris was observed on a skin ex vivo model [6], and this structure was shown to survive on fomites for up to 2 weeks [7].”
BackgroundEnnis, C. L., Hernday, A. D., & Nobile, C. J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01820-21 · Cited by 22 · see citing works
Shivarathri, R., Chauhan, M., Datta, A., Das, D., Karuli, A., Aptekmann, A., Jenull, S., Kuchler, K., Thangamani, S., Chowdhary, A., et al. (2024) · mBio · doi:10.1128/mbio.02748-24 · Cited by 22 · see citing works
“Since C. auris exhibits a predilection for the dermal association, we grew the fungus in the synthetic sweat medium (51) and quantified the aforementioned cell surface carbohydrates.”
Small molecules for combating multidrug-resistant superbug Candida auris infections
Tu, J., Liu, N., Huang, Y., Yang, W., & Sheng, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.001 · Cited by 26 · see citing works
“The compound ceragenin CSA131 (54) had potent fungistatic and fungicidal activity against a set of 100 C. auris clinical isolates (MIC range: 0.5e8 mg/mL; MFC range: 2e64 mg/mL) and was generally more potent than fluconazole, caspofungin, and amphotericin B163.”
BackgroundWeerasinghe, H., Stölting, H., Rose, A. J., & Traven, A. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00171-22 · Cited by 26 · see citing works
“Candida auris , the newest human fungal pathogen of concern, is an effective skin colonizer and may contaminate medical devices as an infection route (24, 25).”
Ume6-dependent pathways of morphogenesis and biofilm formation in <i>Candida auris</i>
Louvet, M., Li, J., Brandalise, D., Bachmann, D., Sala de Oyanguren, F., Labes, D., Jacquier, N., Genoud, C., Mucciolo, A., Coste, A. T., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01531-24 · Cited by 20 · see citing works
Modeling Candida auris skin colonization: Mice, swine, and humans
Eix, E. F., & Nett, J. E. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010730 · Cited by 19 · see citing works
Self-citationSpoladori, L. F. D. A., Andriani, G. M., de Castro, I. M., Suzukawa, H. T., Gimenes, A. C. R., Bartolomeu-Gonçalves, G., Ishida, K., Nakazato, G., Pinge‐Filho, P., Machado, R. R. B., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12050861 · Cited by 19 · see citing works
“auris’s ability to survive for a long period in humans [7,11] and on abiotic surfaces [12–15], as well as in the antifungal resistance [12–14,16,17].”
BackgroundAkinbobola, A., Kean, R., & Quilliam, R. S. (2023) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2023.115841 · Cited by 18 · see citing works
Barbian, H. J., Lie, L., Kittner, A., Harrington, A., Carson, J. S., Frias, M., Slade, D. H., Kim, D. Y., Black, S. R., Parada, J. P., et al. (2025) · Emerging infectious diseases · doi:10.3201/eid3103.241195 · Cited by 17 · see citing works
“Prolonged skin colonization and environmental contamination likely contribute to within-facility persistence and spread ( 2 – 5 ).”
Candida auris biofilm: a review on model to mechanism conservation
Khari, A., Biswas, B., Gangwar, G., Thakur, A., & Puria, R. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2179036 · Cited by 18 · see citing works
“albicans, on the other hand, revealed no fungal development [8].”
BackgroundThe Gordian Knot of C. auris: If You Cannot Cut It, Prevent It
Rapti, V., Iliopoulou, K., & Poulakou, G. (2023) · Pathogens · doi:10.3390/pathogens12121444 · Cited by 16 · see citing works
Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates
Das, S. K., Singh, S., Tawde, Y., Dutta, T. K., Rudramurthy, S. M., Kaur, H., Shaw, T., & Ghosh, A. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32386 · Cited by 16 · see citing works
“These biofilms are shown to be highly resilient to desiccation, osmotic stress and commonly used hospital disinfectants (chlorhexidine and hydrogen peroxide) [18,20 – 22].”
BackgroundDeng, Y., Xu, M., Li, S., Bing, J., Zheng, Q., Huang, G., Liao, W., Pan, W., & Tao, L. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012362 · Cited by 16 · see citing works
Comparing the effect of Thymus spp. essential oils on Candida auris
Ribeiro, R., Fernandes, L., Costa, R. S., Cavaleiro, C., Salgueiro, L., Henriques, M., & Rodrigues, M. E. (2022) · Industrial Crops and Products · doi:10.1016/j.indcrop.2022.114667 · Cited by 18 · see citing works
Essential Oils in Respiratory Mycosis: A Review
Zuzarte, M., & Salgueiro, L. (2022) · Molecules · doi:10.3390/molecules27134140 · Cited by 16 · see citing works
“This fungus also presents a high risk of transmission as it persists on several equipment and medical devices [74].”
BackgroundCheong, J. Z. A., Liu, A., Rust, C. J., et al. (2022) · Wound Repair and Regeneration · doi:10.1111/wrr.13044 · Cited by 15 · see citing works
“The following protocol was adapted from Horton et al.36 Briefly, ex vivo human skin wounds were rinsed with PBS and fixed overnight in 5 ml of 1.5% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.2) at 4 C. Samples were rinsed, treated with 1% osmium tetroxide for 1 h, and then washed again.”
MethodInfluentialSelf-citationClonal Dissemination of Antifungal-Resistant Candida haemulonii, China
Chen, X., Jia, X., Bing, J., Zhang, H., Hong, N., Liu, Y., Xi, H., Wang, W., Liu, Z., Zhang, Q., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2903.221082 · Cited by 14 · see citing works
“C. auris has a potent ability to colonize humans and persist in the hospital environment, and biofilm formation is considered the main contributor ( 34 ).”
Efficacy of gaseous ozone and UVC radiation against Candida auris biofilms on polystyrene surfaces
Epelle, E. I., Amaeze, N., Mackay, W. G., & Yaseen, M. (2024) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2024.113862 · Cited by 14 · see citing works
“Similarly, Horton et al. [34] indicated that when C. auris was cultured in synthetic sweat medium and on porcine skin, robust biofilms that thrive under conditions of evaporation and desiccation were formed.”
Extracellular vesicles contribute to mixed-fungal species competition during biofilm initiation
Zarnowski, R., Massey, J., Mitchell, A. P., & Andes, D. (2022) · mBio · doi:10.1128/mbio.02988-22 · Cited by 15 · see citing works
Bacterial viability in dry-surface biofilms in healthcare facilities: a systematic review
Schapira, A.-J., Dramé, M., Olive, C., & Marion‐Sanchez, K. (2023) · Journal of Hospital Infection · doi:10.1016/j.jhin.2023.11.004 · Cited by 13 · see citing works
Honorato, L., Bonilla, J. J. A., da Silva, L. R., Kornetz, J., Zamith‐Miranda, D., Valdez, A. F., Nosanchuk, J. D., Fox, E. G. P., & Nimrichter, L. (2024) · Virulence · doi:10.1080/21505594.2024.2413329 · Cited by 13 · see citing works
“Furthermore, C. auris is a persistent skin colonizer and can be transmitted from patients to healthcare workers, initiating a chain of transmission to other patients [21,22].”
BackgroundCandida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives
Fernandes, L., Ribeiro, R., Henriques, M., & Rodrigues, M. E. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04497-2 · Cited by 14 · see citing works
Katsiari, M., Nikolaou, C., Palla, E., Theodoridou, K., Tsakris, A., & Vrioni, G. (2025) · Pathogens · doi:10.3390/pathogens14040328 · Cited by 13 · see citing works
“C. auris can form dense biofilms with up to 30-fold higher cellular burden than C. albicans [39], which are highly resistant to desiccation, osmotic stress, and disinfectants like chlorhexidine and can contaminate the skin of patients and healthcare workers [39,40].”
The adhesin SCF1 mediates Candida auris colonization
Balakumar, A., Bernstein, D., & Thangamani, S. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2023.10.008 · Cited by 11 · see citing works
Candida auris : host interactions, antifungal drug resistance, and diagnostics
Chowdhary, A., Lionakis, M. S., & Chauhan, N. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00187-22 · Cited by 13 · see citing works
“These include ex vivo colonization models using native human and porcine skin (126–129), as well as in vivo murine skin infection models involving epicutaneous and intradermal skin infections to study C. auris -host skin colonization mechanisms (42, 70, 127, 130).”
Cell Surface Expression of Nrg1 Protein in Candida auris
Paudyal, A., & Vediyappan, G. (2021) · Journal of Fungi · doi:10.3390/jof7040262 · Cited by 12 · see citing works
“auris also has a high ability to colonize the skin, as demonstrated using porcine skin as an ex vivo model [15].”
BackgroundInfluentialTools and techniques to identify, study, and control Candida auris
Carty, J., Chowdhary, A., Bernstein, D. A., & Thangamani, S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011698 · Cited by 12 · see citing works
“C . auris is found in acute care settings and long-term care facilities and where it can spread leading to systemic infections [3–6].”
BackgroundKhan, D., Nile, A. H., Tripathi, A., & Bankaitis, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136754 · Cited by 12 · see citing works
“auris biofilms efficiently colonize the skin of immunocompromised patients [64].”
BackgroundOctenidine effectively reduces Candida auris colonisation on human skin
Cerbu, D., Seiser, S., Phan-Canh, T., Moser, D., Freystätter, C., Matiasek, J., Kuchler, K., & Elbe‐Bürger, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-11914-x · Cited by 11 · see citing works
“Consistent with other reports 28,34,77,82 , C. auris is unable to penetrate or breach the intact skin barrier.”
Suppressing the virulence factors of Candida auris with baicalein through multifaceted mechanisms
Li, C., Wang, J., Li, H., Wang, Y., Wu, H., Wei, W., Wu, D., Shao, J., Wang, T., & Wang, C. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04038-9 · Cited by 12 · see citing works
“Following a 24-h incubation at 37 °C with 5% CO 2 but without humidity, the skin samples were prepared for SEM and plated for viability assessment (Horton et al. 2020).”
Squitieri, D., Rizzo, S., Torelli, R., Mariotti, M., Sanguinetti, M., Cacaci, M., & Bugli, F. (2025) · Pharmaceuticals · doi:10.3390/ph19010008 · Cited by 11 · see citing works
Biswas, B., Rana, A., Gupta, N., Gupta, I., Puria, R., & Thakur, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00892-23 · Cited by 10 · see citing works
Enablers of Candida auris persistence on medical devices and their mode of eradication.
Nwachukwu, K. C., Nwarunma, E., Uchenna, C. D., & Ugbogu, O. C. (2023) · PubMed Central · doi:10.18502/cmm.2023.150673 · Cited by 10 · see citing works
Balkrishna, A., Kharayat, B., Rastogi, S., Kabdwal, M., Haldar, S., & Varshney, A. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad087 · Cited by 10 · see citing works
Wells, K. M., Ciftci, Y., Peddinti, B. S. T., Ghiladi, R. A., Vediyappan, G., Spontak, R. J., & Govind, R. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.08.088 · Cited by 9 · see citing works
Fayed, B. E., Shakartalla, S. B., Sabbah, H., Dalle, H., Tannira, M., Senok, A. C., & Soliman, S. S. M. (2024) · Mycopathologia · doi:10.1007/s11046-024-00868-9 · Cited by 8 · see citing works
“With the recent reports that highlighted the enhanced ability of C. auris biofilm to colonize the host skin [12], human dermal cells were selected in the present study.”
Junqueira, J. C., & Mylonakis, E. E. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1128600 · Cited by 9 · see citing works
Nicklas, J. P., Deming, C., Lee-Lin, S., Conlan, S., Shen, Z., Blaustein, R. A., & Segre, J. A. (2026) · mBio · doi:10.1128/mbio.03117-25 · Cited by 8 · see citing works
“Horton et al. (21) demonstrated that C. auris grows and colonizes skin to a greater extent than Candida albicans in a pig skin model supplemented with synthetic sweat medium (21).”
Elshaer, M. Y. S., Herrada, J., Gamal, A., McCormick, T. S., & Ghannoum, M. A. (2022) · American Journal of Infection Control · doi:10.1016/j.ajic.2022.11.010 · Cited by 8 · see citing works
Vertebrate and invertebrate animal infection models of Candida auris pathogenicity
Martinez, M., Garsin, D. A., & Lorenz, M. C. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102506 · Cited by 8 · see citing works
Differential susceptibility of Candida (Candidozyma) auris clades to surface disinfectants
Lang, A., Gabriel, H., Meister, T. L., Meis, J. F. G. M., Steinmann, E., Brill, F. H. H., & Steinmann, J. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.10.003 · Cited by 10 · see citing works
Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl
Biermann, A. R., & Hogan, D. A. (2022) · mSphere · doi:10.1128/msphere.00124-22 · Cited by 8 · see citing works
Modeling Candida auris Colonization on Porcine Skin Ex Vivo
Johnson, C. J., Cheong, J., Shanmuganayagam, D., Kalan, L., & Nett, J. E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_20 · Cited by 8 · see citing works
Self-citationTuan, D. A., & Masák, J. (2026) · Current Microbiology · doi:10.1007/s00284-025-04713-0 · Cited by 10 · see citing works
De-la-Pinta, I., Marcos‐Arias, C., Sevillano, E., Eraso, E., & Quindós, G. (2026) · Microorganisms · doi:10.3390/microorganisms14020367 · Cited by 7 · see citing works
“As a result, healthcare workers’ garments may function as mobile reservoirs, facilitating indirect transmission within the hospital ecosystem [60,71].”
InfluentialAn Immunocompromised Mouse Model of Candida auris Systemic Infection
Herrada, J., Roberts, K. D., Gamal, A., Long, L. A., & Ghannoum, M. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_25 · Cited by 7 · see citing works
Hansanant, N., Cao, K., Tenorio, A., et al. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00777 · Cited by 7 · see citing works
The Importance of Candida auris in Skin
Montoya, A. M. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00487-3 · Cited by 6 · see citing works
“The ex vivo pig skin model replicated the findings in SSM, with 15 times greater burden of C. auris when compared to C. albicans [30].”
InfluentialChalin, A., Arvor, A., Hervault, A.-S., Plaisance, M., Niol, L., Simon, S., & Volland, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1439273 · Cited by 6 · see citing works
A Fungus for Our Time: Candida auris Emerges into the Anthropocene
Stephenson, J. C., Garza, D. R., & Bouklas, T. (2023) · Current Tropical Medicine Reports · doi:10.1007/s40475-023-00293-w · Cited by 6 · see citing works
“C. auris is an efficient colonizer of the skin surface and hair follicles, but it does not typically compromise the skin or invade other tissues spontaneously [18].”
InfluentialGlobal characteristics and trends in research on Candida auris
Wang, Q., Cheng, S., Wang, Y., Li, F., Chen, J., Du, W., Kang, H., & Wang, Z. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1287003 · Cited by 6 · see citing works
A Human Ex Vivo Skin Model to Study Candida auris Biofilms
Corzo-León, D., Mark, C., MacCallum, D. M., & Munro, C. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_21 · Cited by 6 · see citing works
Host defense mechanisms against Candida auris
Pechacek, J., & Lionakis, M. S. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2264500 · Cited by 5 · see citing works
“This tendency to colonize the skin for long periods of time has contributed to C. auris’s ability to spread in healthcare settings [22,23] and presents a risk to the colonized individual to subsequently develop invasive candidiasis with C. auris with reports of up to 4–20% of colonized patients…”
BackgroundResultInfluentialCox, C. A., Manavathu, E. K., Wakade, S., Myntti, M. F., & Vázquez, J. A. (2023) · Mycoses · doi:10.1111/myc.13684 · Cited by 6 · see citing works
Merrill, E. D., Prudent, V., Basso, P., Rapp, E., Moghadam, P., Rodriguez, A., Hung, E., Hurabielle, C., Cheng, J., Cho, R. J., et al. (2026) · Science · doi:10.1126/science.adu6688 · Cited by 5 · see citing works
Zarnowski, R., Horton, M. V., Johnson, C. J., Vang, P. C., Uram, J., Fernando, L. D. P., Vlach, J., Heiss, C., Azadi, P., Nett, J. E., et al. (2025) · mBio · doi:10.1128/mbio.00346-25 · Cited by 5 · see citing works
Self-citation
- Authors
- Horton, M. V., Johnson, C. J., Kernien, J. F., Patel, T. D., Lam, B. C., Cheong, J. Z. A., Meudt, J. J., Shanmuganayagam, D., Kalan, L. R., & Nett, J. E.
- Affiliations
- University of Wisconsin–Madison (US)
- ORCID
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2020-02-26
- Volume
- 5
- Issue
- 1
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC6977180
- OpenAlex
- W2999046918
- Cited by
- 159
- References
- 33
- Citations by year
- 2026: 34 · 2025: 19 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 14 · 2020: 11
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- mSphere (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- HHS | National Institutes of Health (K08 AI108727)
- Burroughs Wellcome Fund (1012299)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida auris, biofilm formation, sweat, porcine skin model, hospital-acquired fungal infection, environmental persistence, emerging fungal pathogens
- MeSH terms
- Animals, Candida, Skin, Sweat, Swine, Biofilms, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-20.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-20.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review